To this end, we established the pre-clinical tumor model via subcutaneously implanting B16F10 melanoma cells into C57BL/6 mice with or without the knockdown of SIRT7 and the mice then received the intraperitoneal injection with anti-PD-1 antibody (Fig. 6f). The gene discussed is SIRT7; the disease is melanoma.